Frank Buttgereit mostly deals with Glucocorticoid, Internal medicine, Immunology, Rheumatoid arthritis and Adverse effect. His Glucocorticoid research integrates issues from Steroid hormone, Methylprednisolone, Pharmacology and Mechanism of action. His research on Internal medicine focuses in particular on Rheumatology.
His work deals with themes such as Cancer research and Mesenchymal stem cell, which intersect with Immunology. His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Body mass index and Arthritis. His studies in Adverse effect integrate themes in fields like Clinical trial, MEDLINE, Intensive care medicine, Prednisone and Physical therapy.
Frank Buttgereit mainly focuses on Internal medicine, Rheumatoid arthritis, Immunology, Glucocorticoid and Endocrinology. His research integrates issues of Gastroenterology and Placebo in his study of Internal medicine. His Rheumatoid arthritis research is multidisciplinary, incorporating elements of Physical therapy, Adverse effect, Randomized controlled trial and Prednisone.
Frank Buttgereit combines subjects such as Peripheral blood mononuclear cell and Pharmacology with his study of Glucocorticoid. His Endocrinology research incorporates themes from Cytokine and Osteoblast. He has included themes like Evidence-based medicine and MEDLINE in his Intensive care medicine study.
His main research concerns Internal medicine, Rheumatoid arthritis, Bone healing, Mesenchymal stem cell and Adverse effect. His study brings together the fields of MEDLINE and Internal medicine. His studies in Rheumatoid arthritis integrate themes in fields like Arthritis, Adrenal insufficiency and Glucocorticoid.
His Bone healing research integrates issues from Cancer research, RUNX2, Tofacitinib, Osteotomy and Bone regeneration. Frank Buttgereit has included themes like Immune system, In vitro, Cartilage and Cytokine in his Mesenchymal stem cell study. His biological study spans a wide range of topics, including Disease and Intensive care medicine.
Frank Buttgereit focuses on Internal medicine, Rheumatoid arthritis, Bone healing, Adverse effect and Giant cell arteritis. All of his Internal medicine and Rheumatology, Glucocorticoid, Prednisone, Disease and Tocilizumab investigations are sub-components of the entire Internal medicine study. His research integrates issues of Early arthritis and Glucocorticoid receptor in his study of Rheumatology.
His work carried out in the field of Glucocorticoid brings together such families of science as Regimen, Toxicity and Arthritis. His work deals with themes such as Randomized controlled trial and Osteoporosis, which intersect with Rheumatoid arthritis. The study incorporates disciplines such as Glasgow Coma Scale, Rheumatism and High doses in addition to Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)
Genomic and nongenomic effects of glucocorticoids.
Cindy Stahn;Frank Buttgereit.
Nature Reviews Rheumatology (2008)
Quantitating Protein Synthesis, Degradation, and Endogenous Antigen Processing
Michael F. Princiotta;Diana Finzi;Shu-Bing Qian;James Gibbs.
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
J A P Da Silva;J W G Jacobs;J R Kirwan;M Boers.
Annals of the Rheumatic Diseases (2006)
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology
F. Buttgereit;J.A. da Silva;M. Boers;G.R. Burmester.
Annals of the Rheumatic Diseases (2002)
EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
J. N. Hoes;J. W. G. Jacobs;M. Boers;D. Boumpas.
Annals of the Rheumatic Diseases (2007)
Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists
Cindy Stahn;Mark Löwenberg;Daniel W. Hommes;Frank Buttgereit.
Molecular and Cellular Endocrinology (2007)
Association Among Rheumatoid Arthritis, Oral Hygiene, and Periodontitis
N. Pischon;T. Pischon;J. Kröger;E. Gülmez.
Journal of Periodontology (2008)
Dose-related patterns of glucocorticoid-induced side effects
Dörte Huscher;Katja Thiele;Erika Gromnica-Ihle;Gert Hein.
Annals of the Rheumatic Diseases (2009)
Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action.
Frank Buttgereit;Rainer H Straub;Martin Wehling;Gerd-Rüdiger Burmester.
Arthritis & Rheumatism (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: